Aclaris Therapeutics shares fall on wider Q1 loss

Aclaris Therapeutics

08/05/2023 14:10

** Shares of Aclaris Therapeutics Inc  ACRS.O  down 7% at
$8.35 premarket
    ** Co reports wider first-quarter net loss per share of
$0.42 compared to loss of $0.31 per share in prior year
    ** Reports Q1 2023 revenue of $2.5 million, up from $1.5
million in Q1 2022
    ** Says had cash, cash equivalents and marketable securities
of $204.4 million as of March 31, 2023
    ** Sees cash runway through the end of 2025
    ** Up to last close, stock has fallen 42.98% so far this
year

 (Reporting by Raechel Thankam Job)
 ((RaechelThankam.Job@thomsonreuters.com;))